Oligonucleotide Synthesis Market Size Worth USD 9.91 Billion by 2027 | The Growing Focus on Customized Medicine and the Rising Funding for Synthetic Biology is Driving Industry Growth, says Emergen Research

Key participants in Oligonucleotide Synthesis market include GeneDesign, Inc., Sarepta Therapeutics, Inc., Thermo Fisher Scientific, Inc., Bio-Synthesis, Inc., Agilent Technologies, Inc., Biogen Idec International GmbH, Nitto Denko Avecia, Inc., ATDBio Ltd, Integrated DNA Technologies, Inc., and GenScript, Inc. among others.

/EIN News/ -- Vancouver, British Columbia, March 24, 2021 (GLOBE NEWSWIRE) -- The global Oligonucleotide Synthesis Market is forecasted to be worth USD 9.91 Billion by 2027, according to a current analysis by Emergen Research. Due to the increasing emphasis on personalized medicine, the market for global Oligonucleotide Synthesis is expected to undergo rapid growth over the forecast timeline. Custom medicine provides customized therapy based on patients' requirements and priorities. Synthesis of oligonucleotide offers patients personalized solutions. In the biotech industry, the invention of senseless RNA therapeutic has obtained tremendous traction.

With oligonucleotide synthesis, the future use of personalized medication to cure chronic illnesses is achievable. Besides, the rising funding for synthetic biology is expected to further fuel the market growth. Oligonucleotide product development for diagnostic and therapeutic implementations supported by the increasing development of microarray technology and is expected to stimulate market growth during the projected timeframe.

However, during the projected timeframe, the lack of expertise among professionals is forecasted to hamper oligonucleotide synthesis's market growth.

Claim Your FREE Sample Copy with Table of content@ https://www.emergenresearch.com/request-sample/351

Key Highlights From The Report

• In October 2020, Thermo Fisher Scientific, the global leader in science services, and Symphogen, an associate of the multinational pharmaceutical group and an antibody center of excellence, Servier, announced the expansion of a strategic partnership to provide sector-proven, advanced business processes on classification and quality management for the streamlined analysis of complex protein therapeutics.
• Synthesized oligonucleotides account for the largest market with CAGR of 13.1%. Oligonucleotide synthesis can be defined by the organic compounds of short, designated nucleotide molecules. They are granted the ability to produce genes for proteins that do not usually exist.
• It is expected that the pharmaceutical market will see substantial expansion. Oligonucleotides play a key role in solving challenges linked to the effective administration of medications. In turn, it is expected to enhance therapeutic oligonucleotides' utilization, consequently boosting the market for the pharmaceutical and biotechnology sectors.
• The Asia Pacific region is anticipated to expand significantly throughout the forecast period due to the emergence of the exciting life science research center in the region.
• Key participants include GeneDesign, Inc., Sarepta Therapeutics, Inc., Thermo Fisher Scientific, Inc., Bio-Synthesis, Inc., Agilent Technologies, Inc., Biogen Idec International GmbH, Nitto Denko Avecia, Inc., ATDBio Ltd, Integrated DNA Technologies, Inc., and GenScript, Inc. among others.

Check Our Prices@ https://www.emergenresearch.com/select-license/351
Emergen Research has segmented the global Oligonucleotide Synthesis Market on the basis of product, application, end-use, and region:

• Product Outlook (Revenue, USD Billion; 2017-2027)
  • Linkers
  • Synthesized Oligonucleotides
  • Equipment
  • Probe
  • Adaptor
  • Reagent
• Application Outlook (Revenue, USD Billion; 2017-2027)
  • Therapeutic
  • Research
  • Diagnostics
• End-Use Outlook (Revenue, USD Billion; 2017-2027)
  • Pharmaceutical
  • Hospitals
  • Biotechnology
  • Laboratories

Click to access the Report Study, Read key highlights of the Report and Look at Projected Trends:   https://www.emergenresearch.com/industry-report/oligonucleotide-synthesis-market

• Regional Outlook (Revenue, USD Billion; 2017-2027)
  • North America
    1. U.S.
    2. Canada
    3. Mexico
  • Europe
    1. Germany
    2. UK
    3. France
    4. BENELUX
    5. Rest of Europe
  • Asia Pacific
    1. China
    2. Japan
    3. South Korea
    4. India
    5. Rest of APAC
  • Latin America
    1. Brazil
    2. Rest of LATAM
  • MEA
    1. Saudi Arabia
    2. UAE
    3. Rest of MEA

Take a Look at our Related Reports:

Topical Drug Delivery Market By Product Form (Semi-Solid, Solid Formulations, Transdermal Products, and Liquid Formulations), By Route (Dermal, Ophthalmic, Nasal, Others), By End-Use (Hospitals, Home Healthcare, Clinics, Diagnostic Centers, Burn Center), and By Regions

Medical Smart Textiles Market By Technology (Textile Sensors, Wearable Technology), By Application (Surgery, Bio-Monitoring, Therapy, and Wellness), By End-use (Hospitals and Clinics, Medical Academic and Research Center), and By Region

Operating Room Management Solutions Market By Solution Type (Data management and communication solutions, Operating room supply management solutions, Anesthesia information management solutions, Operating room scheduling solutions, Performance management solutions), By Mode of Deployment (Ob-premises, Cloud-based), By End-Use (Hospitals, Ambulatory surgical centers), and By Region

Patient Registry Software Market By Delivery, By Database, By Registry Type, By Function, By Software Type (Integrated, Standalone), By End-use (Government & Third-Party Administrators, Pharmaceutical Companies, Hospitals, Research Centers, Others), and By Region, Forecast to 2027

Ambulatory EHR Market By Deployment (Cloud-based, On-premises), By Practice Size (Solo Practices, Large Practices, Small-medium-sized Practices), By Application, By End-use (Independent Centers, Hospital-owned Ambulatory Centers, Others), and By Region, Forecasts to 2027

About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Facebook | LinkedIn | Twitter | Blogs

Read Full Press Release: https://www.emergenresearch.com/press-release/global-oligonucleotide-synthesis-market